Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 168905, 14 pages
http://dx.doi.org/10.1155/2015/168905
Review Article

Drug Induced Steatohepatitis: An Uncommon Culprit of a Common Disease

Liver Unit, Department of Gastroenterology, Tel Aviv Medical Center, 6423906 Tel Aviv, Israel

Received 24 October 2014; Revised 27 January 2015; Accepted 4 February 2015

Academic Editor: Fabio Galvano

Copyright © 2015 Liane Rabinowich and Oren Shibolet. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [19 citations]

The following is the list of published articles that have cited the current article.

  • Ansheng Zou, Haili Jiang, Ju Liu, Haifeng Teng, Meng Chen, Jichun Han, Long Sun, and Chao Feng, “Hepatoprotective effects of licochalcone B on carbon tetrachloride-induced liver toxicity in mice,” Iranian Journal of Basic Medical Sciences, vol. 19, no. 8, pp. 910–915, 2016. View at Publisher · View at Google Scholar
  • Junichiro Kumagai, Tatsuo Kanda, Shin Yasui, Yuki Haga, Reina Sasaki, Masato Nakamura, Shuang Wu, Shingo Nakamoto, Makoto Arai, Yotaro Iino, and Osamu Yokosuka, “Autoimmune hepatitis following drug-induced liver injury in an elderly patient,” Clinical Journal of Gastroenterology, 2016. View at Publisher · View at Google Scholar
  • Laia Tolosa, M. José Gómez-Lechón, Nuria Jiménez, David Hervás, Ramiro Jover, and M. Teresa Donato, “Advantageous use of HepaRG cells for the screening and mechanistic study of drug-induced steatosis,” Toxicology and Applied Pharmacology, 2016. View at Publisher · View at Google Scholar
  • Rolf Teschke, and Gaby Danan, “Drug-induced liver injury: Is chronic liver disease a risk factor and a clinical issue?,” Expert Opinion on Drug Metabolism & Toxicology, vol. 13, no. 4, pp. 425–438, 2016. View at Publisher · View at Google Scholar
  • Ajit Dash, Robert A. Figler, Arun J. Sanyal, and Brian R. Wamhoff, “Drug-induced steatohepatitis,” Expert Opinion on Drug Metabolism & Toxicology, vol. 13, no. 2, pp. 193–204, 2016. View at Publisher · View at Google Scholar
  • Namki Hong, Han Gyul Yoon, Da Hea Seo, Seho Park, Seung Il Kim, Joo Hyuk Sohn, and Yumie Rhee, “Different patterns in the risk of newly developed fatty liver and lipid changes with tamoxifen versus aromatase inhibitors in postmenopausal women with early breast cancer: A propensity score?matched cohort study,” European Journal of Cancer, vol. 82, pp. 103–114, 2017. View at Publisher · View at Google Scholar
  • Ishani Wickramage, Kamani Hemamala Tennekoon, Asanka Sudeshini Hewage, Merenchi Arachchige Yasantha Ariyaratne, and Tharmini Sundralingam, “CYP2D6 polymorphisms may predict occurrence of adverse effects to tamoxifen: A preliminary retrospective study,” Breast Cancer: Targets and Therapy, vol. 9, pp. 111–120, 2017. View at Publisher · View at Google Scholar
  • Julie Massart, Karima Begriche, Caroline Moreau, and Bernard Fromenty, “Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity.,” Journal of clinical and translational research, vol. 3, no. Suppl1, pp. 212–232, 2017. View at Publisher · View at Google Scholar
  • Iván José Ardila Gómez, Carolina Bonilla González, Paula Andrea Martínez Palacio, Elida Teresa Mercado Santis, José Daniel Tibaduiza Bayona, Juan Pablo Contreras Hernández, and Jaime Fernández Sarmiento, “Nutritional Support of the Critically Ill Pediatric Patient: Foundations and Controversies,” Clinical Medicine Insights: Trauma and Intensive Medicine, vol. 8, pp. 117956031770110, 2017. View at Publisher · View at Google Scholar
  • Jose Ignacio Vargas, Juan Pablo Arab, Fernando Bessone, Maria Isabel Lucena, Raul J. Andrade, and Marco Arrese, “Hepatotoxicity in Patients with Metabolic Syndrome: Causes and Consequences,” Current Hepatology Reports, 2017. View at Publisher · View at Google Scholar
  • Jichun Han, Dong Wang, Defang Li, Xiaoyu Chen, Fenghua Wang, Xiaona Liu, Jing Shang, Qiusheng Zheng, and Bo Wang, “Licochalcone e protects against carbon tetrachloride-induced liver toxicity by activating peroxisome proliferator-activated receptor gamma,” Molecular Medicine Reports, vol. 16, no. 4, pp. 5269–5276, 2017. View at Publisher · View at Google Scholar
  • Judith Sommer, Kim Freese, Tobias S. Schiergens, Martina Müller, Anja K. Bosserhoff, Claus Hellerbrand, Abdo Mahli, Fulya Suzan Kuecuekoktay, Andreas Teufel, and Wolfgang E. Thasler, “Analysis of molecular mechanisms of 5-fluorouracil-induced steatosis and inflammation in vitro and in mice,” Oncotarget, vol. 8, no. 8, pp. 13059–13072, 2017. View at Publisher · View at Google Scholar
  • Aida Ortega-Alonso, and Raúl J Andrade, “Chronic liver injury induced by drugs and toxins,” Journal of Digestive Diseases, 2018. View at Publisher · View at Google Scholar
  • Mari Ochiai, Midori Iida, Tetsuro Agusa, Kohki Takaguchi, Satoshi Fujii, Kei Nomiyama, and Hisato Iwata, “Effects of 4-Hydroxy-2,3,3′,4′,5-Pentachlorobiphenyl (4-OH-CB107) on Liver Transcriptome in Rats: Implication in the Disruption of Circadian Rhythm and Fatty Acid Metabolism,” Toxicological Sciences, 2018. View at Publisher · View at Google Scholar
  • Rocío Aller, Conrado Fernández-Rodríguez, Oreste lo Iacono, Rafael Bañares, Javier Abad, José Antonio Carrión, Carmelo García-Monzón, Joan Caballería, Marina Berenguer, Manuel Rodríguez-Perálvarez, José López Miranda, Eduardo Vilar-Gómez, Javier Crespo, Miren García-Cortés, María Reig, José María Navarro, Rocío Gallego, Joan Genescà, María Teresa Arias-Loste, María Jesús Pareja, Agustín Albillos, Jordi Muntané, Francisco Jorquera, Elsa Solà, Manuel Hernández-Guerra, Miguel Ángel Rojo, Javier Salmerón, Llorenc Caballería, Moisés Diago, Esther Molina, Ramón Bataller, and Manuel Romero-Gómez, “Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline,” Gastroenterología y Hepatología (English Edition), 2018. View at Publisher · View at Google Scholar
  • Rocío Aller, Conrado Fernández-Rodríguez, Oreste lo Iacono, Rafael Bañares, Javier Abad, José Antonio Carrión, Carmelo García-Monzón, Joan Caballería, Marina Berenguer, Manuel Rodríguez-Perálvarez, José López Miranda, Eduardo Vilar-Gómez, Javier Crespo, Miren García-Cortés, María Reig, José María Navarro, Rocío Gallego, Joan Genescà, María Teresa Arias-Loste, María Jesús Pareja, Agustín Albillos, Jordi Muntané, Francisco Jorquera, Elsa Solà, Manuel Hernández-Guerra, Miguel Ángel Rojo, Javier Salmerón, Llorenc Caballería, Moisés Diago, Esther Molina, Ramón Bataller, and Manuel Romero-Gómez, “Documento de consenso. Manejo de la enfermedad hepática grasa no alcohólica (EHGNA). Guía de práctica clínica,” Gastroenterología y Hepatología, 2018. View at Publisher · View at Google Scholar
  • Nkomozepi, Lembede, Erlwanger, and Chivandi, “Effect of neonatal orally administered S-allyl cysteine in high-fructose diet fed Wistar rats,” Journal of Developmental Origins of Health and Disease, vol. 9, no. 2, pp. 160–171, 2018. View at Publisher · View at Google Scholar
  • B. Claire McDyre, Mohamed Diwan M. AbdulHameed, Matthew G. Permenter, William E. Dennis, Christine E. Baer, Jason M. Koontz, Molly H. Boyle, Anders Wallqvist, John A. Lewis, and Danielle L. Ippolito, “Comparative Proteomic Analysis of Liver Steatosis and Fibrosis after Oral Hepatotoxicant Administration in Sprague-Dawley Rats,” Toxicologic Pathology, pp. 019262331774754, 2018. View at Publisher · View at Google Scholar
  • James E. Klaunig, Xilin Li, and Zemin Wang, “Role of xenobiotics in the induction and progression of fatty liver disease,” Toxicology Research, 2018. View at Publisher · View at Google Scholar